Delivery Order SPE2DX22D0010-SPE2D826FAC84
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Amphetamine Mix (AD) Extended Release Capsules 25mg with a ceiling value of $4,271.13. The contract is structured as a firm fixed price delivery order with an ultimate completion date of July 24, 2025, and was awarded on July 23, 2025. No set-aside designation was applied to this competitive award. AmerisourceBergen Drug Corp will perform the work at its corporate office...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 30, 2025, for the supply of Amphetamine Mix (AD) Extended Release Capsules 20mg. This competitively awarded, non-set-aside contract represents a firm fixed-price delivery order with a ceiling value of $1,055.37 and an ultimate completion date of October 1, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency's Medical Supply Chain awarded a $3,866.96 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Amphetamine Mix (AD) extended-release capsules, 25mg. The contract was executed on June 23, 2025, with an ultimate completion date of June 24, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This was a competitive award with no set-aside designation. This delivery order represents a child contract under...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a $4,408.02 delivery order to AmerisourceBergen Drug Corp for Amphetamine Mix (AD) extended-release capsules, 25 mg, with a completion date of September 9, 2025. This is a firm fixed-price, non-set-aside contract awarded competitively on September 8, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement and military healthcare systems....
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Amphetamine Mix extended-release capsules at 37.5 mg dosage strength. This competitive delivery order, valued at $1,094.39, represents a firm fixed-price procurement with an ultimate completion date of August 14, 2025. The contract is classified as a child award, indicating it derives from a larger indefinite delivery contract vehicle. Performance of...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 16, 2025, for Amphetamine Mix Extended-Release Capsules 25mg, with a ceiling value of $1,161.88 and an ultimate completion date of September 17, 2025. This competitively awarded, non-set-aside contract represents a pharmaceutical supply delivery under the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency Medical Supply Chain awarded a $1,267.87 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Amphetamine Mix Tablets 5MG, with an ultimate completion date of August 1, 2025. This non-competitive delivery order represents a routine pharmaceutical procurement under the company's existing contract vehicle. The award was issued to AmerisourceBergen's Corporate Office division, with performance taking place at the contractor's facility in Conshohocken,...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Amphetamine Mix Tablets 20mg, with a ceiling value of $2,454.12 and an ultimate completion date of August 12, 2025. This is a firm fixed price delivery order with no set-aside designation, awarded through competitive procedures. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Amphetamine Mix Tablets 20mg with a ceiling value of $2,386.80. This firm fixed-price delivery order, issued on August 21, 2025, with an ultimate completion date of August 22, 2025, represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement. The contract involves no set-aside designation and will be performed at the contractor's facility in...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Amphetamine Mix Tablets 20mg, valued at $1,989.00. This firm fixed-price delivery order, with an ultimate completion date of August 6, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal medical procurement...
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D826FAC84Delivery Order
The Defense Logistics Agency Medical Supply Chain has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Amphetamine Mix (AD) Extended Release Capsules 25mg, with a ceiling value of $3,780.69. The contract is a firm fixed price delivery order with an ultimate completion date of October 7, 2025, awarded on October 6, 2025. No set-aside designation was applied to this award, indicating it was competitively procured. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is performing the work at its corporate office location. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion and running through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The underlying IDC encompasses specialty medications, branded and generic drugs, vaccines, and related medical commodities across multiple therapeutic domains, supporting the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.8k | 10/6/25 |